ITH advances in the surgical management of acoustic neuroma over the last three decades, total tumor removal can now be achieved in the majority of cases, with no deaths and a minimal incidence of morbidity. In addition, the advent of magnetic resonance imaging has potentially allowed the early detection of acoustic neuromas while they are small and are associated with good hearing. Attention has been increasingly focused on hearing preservation following total tumor removal.
40-dB sensation level or maximum comfortable loudness, whichever was less. Facial nerve outcomes were reported according to the House-Brackmann system; the most recent status recorded during follow-up examinations was used. 12 Patients were considered candidates for hearing preservation surgery if the affected ear retained a PTA of less than 50 dB and an SDS of greater than 50% (Class B or better). For patients electing hearing preservation surgery, the size and the anatomical location of the tumor influenced the choice of surgical approach. Tumors confined to the IAC or those that extended less than 3 mm outside the porus acusticus were removed via the middle fossa approach. The retrosigmoid approach was used in hearing preservation surgery for tumors exceeding the limits for the middle fossa approach. For all other patients in whom no attempt was made to preserve hearing, the translabyrinthine approach was used. Hearing was considered to be successfully preserved if it remained at a PTA of less than 50 dB and an SDS of greater than 50% (Class B or better).
In all hearing preservation surgery, the tumor was removed in a medial-to-lateral direction accompanied by continuous facial nerve and auditory brainstem response monitoring. The tumor was dissected sharply from the cochlear nerve with a microscissors or blade.
Results
Hearing preservation surgery was attempted in 30 (47.6%) of 63 acoustic neuroma cases treated during the time of this study. This group consisted of 16 men and 14 women who ranged in age from 27 to 68 years (mean 48.9 years). The postoperative hearing level was evaluated 3 to 5 months after surgery (mean 134 days). Table 2 shows raw patient data in each case, consisting of tumor size, facial nerve function, and adhesiveness between the cochlear nerve and the tumor. The middle fossa approach was used in 10 cases, and the retrosigmoid in 20.
Extent of Tumor Resection
The goals in each operation were total removal of the tumor, preservation of facial function, and preservation of hearing. In cases in which all three goals could not be safely met, facial nerve preservation and total tumor removal took precedence over hearing preservation. In 27 patients (90%) we accomplished total removal of the tumor. In three patients (Cases 1, 6, and 7) we intentionally left a small trace (Ͻ 0.5 mm) of tumor capsule that was severely adherent to the facial nerve to preserve this facial nerve's function. In these same three cases with near-total resection, there was also severe tumor adhesion to the cochlear nerve. In two of the three patients (Cases 6 and 7) we could not preserve the cochlear nerve anatomically because of severe adhesion.
Hearing Preservation
In Table 3 we compare the pre-and postoperative hearing results. Seventeen patients had Class A hearing and 13 had Class B hearing preoperatively. The cochlear nerve was anatomically preserved in 28 patients (93.3%). Overall, hearing was preserved (Class B or better) in 21 patients (70%); 22 patients (73.3%) retained Class C or better hearing. Hearing was preserved in seven (70%) of the patients in the middle fossa group, and in 14 (70%) of those in the retrosigmoid group. The mean tumor size was 14.2 mm in the group with, and 20.9 mm in the group without hearing preservation. Although the mean tumor size was not significantly different in these two groups (p = 0.304), it tended to be smaller in the group with preserved hearing. Hearing was preserved in 17 (77.3%) of the 22 patients with tumors smaller than 20 mm and in four (50%) of the eight patients with tumors 20 mm or larger. Although these differences were not statistically different (p = 0.195), the hearing preservation rate was higher in the patients whose tumors were smaller than 20 mm. 
Hearing Preservation and Tumor Adhesion to the Cochlear Nerve
The adhesion between the tumor and the cochlear nerve was evaluated during the procedure by the operating surgeon (T.F.). In the patients with severe adhesion, it was difficult to separate the cochlear nerve from the tumor capsule with blunt dissection, and sharp dissection with scissors was required. There were 11 patients with and 19 without severe adhesion. Hearing was preserved in two (18.2%) of 11 patients with adhesion and in all 19 cases without adhesion; the adhesion had a significant effect on hearing preservation outcomes (p Ͻ 0.0001).
Facial Nerve Preservation
In all cases, the facial nerve was anatomically preserved after surgery. Postoperative facial nerve function was graded at 3 months (mean 94 days) by using the House-Brackmann system. 12 Overall, 27 patients (90%) had Grade I function, two (6.7%) had Grade II, and one (3.3%) remained at Grade IV function; no patient had Grade V or VI postsurgery. The three patients in whom postoperative Grade I function was not attained were the same three in whom a small trace of tumor capsule was intentionally left on the facial nerve because of severe adhesion and to preserve facial nerve function (Cases 1, 6, and 7). Good postoperative function (Grades I and II) was achieved in 95 and 100% of patients following the retrosigmoid and middle fossa approach, respectively. There was no significant difference in facial nerve outcome between these two approaches (p Ͼ 0.999).
Surgical Complications
There were no deaths or major permanent morbidities in this series. There was one case of postoperative cerebrospinal fluid leakage, in which the leak was resolved with a pressure dressing applied to the head. One patient required surgical debridement for wound infection; and in one a pulmonary thrombosis developed, which required prolonged hospitalization and anticoagulation therapy.
Discussion
Controversy continues over patient selection criteria for hearing preservation surgery, as well as the criteria for defining success. It is generally accepted that hearing improvement after acoustic neuroma surgery is rare. Even good preoperative hearing does not always correlate with a better postoperative result. Therefore, it seems logical to attempt hearing preservation surgery only in patients with normal or useable preoperative hearing. We select patients whose preoperative PTA is 50 dB or less and whose SDS is 50% or more (Class B or better) as candidates for hearing preservation surgery, and we consider that hearing was preserved if the patient's classification remained Class B or better postoperatively. It is our belief that this level represents useful hearing for daily life. As for the selection criteria for tumor size, although it is generally accepted that hearing preservation in patients with large tumors is difficult and less likely, there are some cases involving large tumors in which hearing can be preserved. Therefore we agree with some authors 5, 6 that hearing preservation should be attempted if there is good preoperative hearing, despite the size of the tumors.
Preoperative and postoperative raw patient audiological data have been reported in a wide number of studies (Table 4). 1, 2, 4, 5, 8, 10, 11, 13, 14, 17, 18, 20 In our series, Class A results were achieved in 23.3% of the patients, and Class B or better in 70% (Table 3) . Some measurable hearing was preserved in 24 patients (80%). If the two patients with intraoperative cochlear nerve sacrifice are excluded, Class A results were achieved in 25% of patients, Class B or better in 75%, and some measurable hearing in 85.7%. Although it is somewhat difficult to compare the hearing preservation results reported in the literature directly because of the differences in preoperative hearing level and tumor size, the hearing preservation rate in our study is favorable compared with other reports. Despite the fact that tumor size was significantly larger in the group in which the retrosigmoid approach was used (19.5 mm for retrosigmoid and 9.6 mm for middle fossa approach, p Ͻ 0.0001), there was no significant difference between the two approaches for the success rate of hearing preservation surgery (70% for retrosigmoid compared with 70% for middle fossa approach, p Ͼ 0.999).
The statistical comparability of these two approaches supports the contention that individualizing the approach in surgery for hearing preservation is helpful in improving the success rates for hearing preservation after acoustic neuroma surgery. In addition, there was no significant difference in facial nerve function and other morbidity after retrosigmoid or middle fossa surgery. Marked, delayed deteriora- tion of the hearing level was not seen in any of our patients, although it has been reported that delayed deterioration in hearing has occurred years after initially successful hearing preservation surgery. 9, 19 Therefore, longer, careful follow up should be required.
There have been a few reports describing intraoperative findings in relation to the hearing outcome. In their study Koos and Perneczky 14 stated that hearing was preserved postoperatively only in cases in which the cochlear nerve formed a solid bundle and could be differentiated and separated from the tumor capsule without difficulty. Umezu and Aiba 21 reported that the smaller the tumor and/or the better the preoperative hearing levels, the greater the likelihood that the cochlear nerve was morphologically intact, and in such situations hearing could be preserved. Previous histological studies revealed that moderate invasion of tumor cells into the adjacent cochlear nerve was frequently found at the tumor-nerve interface, 7, 16 and severe tumor invasion with concomitant disruption and degeneration of adjacent myelinated nerve fibers was also seen in some cases. 15 These findings are considered to be related to difficulty in separating the tumor from the cochlear nerve, and may result in postoperative hearing loss, despite the anatomical preservation of the cochlear nerve.
Our present study demonstrates that hearing was preserved in only 18.2% of patients with severe adhesion between the cochlear nerve and the tumor capsule, but in 100% of patients without severe adhesion. Although there was a tendency for larger tumors to adhere more severely to the cochlear nerve, some small intracanalicular tumors could be very adherent to the cochlear nerve as well, making dissection difficult. Conversely, some of the larger tumors were less adherent to the cochlear nerve than the smaller ones within the IAC. These findings indicate that the presence or absence of severe adhesion in the interface between the cochlear nerve and the tumor may be the most significant prognostic factor in hearing preservation surgery, regardless of tumor size. In the future, advances in imaging technology may allow preoperative assessment of tumor adhesion, and we hope these changes will result in good patient selection for hearing preservation surgery.
Conclusions
The results of our study demonstrate that the presence or absence of severe adhesion in the interface between the cochlear nerve and the tumor may be the most significant prognostic factor in hearing preservation surgery, regardless of tumor size.
